Download presentation
Presentation is loading. Please wait.
Published byFarida Johan Modified over 5 years ago
1
Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial Jill J.F. Belch, MD, FRCP, John Dormandy, MD, FRCS Journal of Vascular Surgery Volume 52, Issue 4, Pages e2 (October 2010) DOI: /j.jvs Copyright © 2010 Society for Vascular Surgery Terms and Conditions
2
Fig 1 Clopidogrel and Acetylsalicylic acid in bypass Surgery for Peripheral Arterial disease (CASPAR) study design. R = randomization stratified by graft type (venous or prosthetic). ASA, Acetylsalicylic acid. Journal of Vascular Surgery , e2DOI: ( /j.jvs ) Copyright © 2010 Society for Vascular Surgery Terms and Conditions
3
Fig 2 Distribution of patients. ASA, Acetylsalicylic acid.
Journal of Vascular Surgery , e2DOI: ( /j.jvs ) Copyright © 2010 Society for Vascular Surgery Terms and Conditions
4
Fig 3 Kaplan-Meier curves of time to primary outcome event (graft occlusion/revascularization/replacement, amputation above ankle, death) in the total population. CI, Confidence interval; NS, not significant. Journal of Vascular Surgery , e2DOI: ( /j.jvs ) Copyright © 2010 Society for Vascular Surgery Terms and Conditions
5
Fig 4 Kaplan-Meier curves of time to primary outcome event (graft occlusion/revascularization/replacement, amputation above ankle, death) by type of graft (intent-to-treat [ITT] population). CI, Confidence interval; NS, not significant. Journal of Vascular Surgery , e2DOI: ( /j.jvs ) Copyright © 2010 Society for Vascular Surgery Terms and Conditions
6
Fig 5 Kaplan-Meier curves of time to first amputation above the ankle of the affected limb: venous and prosthetic graft groups. CI, Confidence interval; NS, not significant. Journal of Vascular Surgery , e2DOI: ( /j.jvs ) Copyright © 2010 Society for Vascular Surgery Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.